NPPA Revises Coronary Stent Prices, DES at Rs 39,186 and BMS at Rs 10,762 from April 2026
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has notified revised ceiling prices for coronary stents, factoring in the Wholesale Price Index (WPI) increase of 0.64956% for the year 2025 over 2024.
The revised ceiling prices of coronary stents have been fixed at ₹10,762.15 per unit for Bare Metal Stents (BMS), while Drug Eluting Stents (DES), including metallic DES and Bioresorbable Vascular Scaffolds (BVS)/biodegradable stents, have been priced at ₹39,186.03 per unit.These prices are applicable per stent and are exclusive of GST.
The revision has been issued through Order S.O. 1587(E), in continuation of earlier notifications released between 2018 and 2025 regarding price fixation of coronary stents listed under Sl. No. 28 in Schedule-I of the Drugs (Prices Control) Order, 2013. The revised ceiling prices will come into effect from April 1, 2026, exclusive of Goods and Services Tax (GST), as applicable.
The notice stated,
"In continuation of the notifications issued by the National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018, 1464(E) dated 02.04.2018, 1488(E) dated 29.03.2019, 1217(E) dated 25.03.2020, 1334(E) dated 25.03.2021, 1502(E) dated 30.03.2022, 5249(E) dated 11.11.2022, 1572(E) dated 31.03.2023, 4663(E) dated 25.10.2023, 1551(E) dated 26.03.2024, 1605(E) dated 03.04.2024 and 1473(E) dated 27.03.2025 regarding the fixation of ceiling price of the Coronary Stents as specified in column no. (2) mentioned in the table below; after considering the Wholesale Price Index (WPI) @ 0.64956% for the year 2025 over 2024, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2026, as under:
Sl. No. | Coronary Stents (Sl. No. 28 in Schedule-I of the DPCO, 2013) | Unit (in Number) | Ceiling Price (w.e.f. 01.04.2026 with WPI @ 0.64956%) (in Rs) |
(1) | (2) | (3) | (4) |
1 | Bare Metal Stents | 1 | 10,762.15 |
2 | Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular Scaffold (BVS)/Biodegradable Stents | 1 | 39,186.03 |
Further, the notification added,
(a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 0.64956% for the year 2025 over 2024 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013.
(b) The manufacturers/ importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table.
(c) As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
To view the official notice, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.